Logo image of SJ

SCIENJOY HOLDING CORP-A (SJ) Stock Fundamental Analysis

NASDAQ:SJ - VGG7864D1125 - Common Stock

0.7509 USD
+0 (+0.64%)
Last: 8/22/2025, 8:00:02 PM
Fundamental Rating

5

SJ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 75 industry peers in the Entertainment industry. While SJ has a great health rating, its profitability is only average at the moment. SJ is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SJ had positive earnings in the past year.
SJ had a positive operating cash flow in the past year.
Of the past 5 years SJ 4 years were profitable.
In the past 5 years SJ always reported a positive cash flow from operatings.
SJ Yearly Net Income VS EBIT VS OCF VS FCFSJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

With a decent Return On Assets value of 2.82%, SJ is doing good in the industry, outperforming 76.00% of the companies in the same industry.
SJ has a better Return On Equity (3.31%) than 74.67% of its industry peers.
SJ has a Return On Invested Capital of 2.22%. This is in the better half of the industry: SJ outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SJ is significantly below the industry average of 23.16%.
Industry RankSector Rank
ROA 2.82%
ROE 3.31%
ROIC 2.22%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
SJ Yearly ROA, ROE, ROICSJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

SJ has a Profit Margin of 2.91%. This is in the better half of the industry: SJ outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of SJ has declined.
With a decent Operating Margin value of 2.99%, SJ is doing good in the industry, outperforming 68.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SJ has declined.
SJ has a Gross Margin of 18.00%. This is in the lower half of the industry: SJ underperforms 73.33% of its industry peers.
SJ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.99%
PM (TTM) 2.91%
GM 18%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
SJ Yearly Profit, Operating, Gross MarginsSJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SJ is destroying value.
The number of shares outstanding for SJ has been increased compared to 1 year ago.
Compared to 5 years ago, SJ has more shares outstanding
There is no outstanding debt for SJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SJ Yearly Shares OutstandingSJ Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SJ Yearly Total Debt VS Total AssetsSJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SJ has an Altman-Z score of 2.76. This is not the best score and indicates that SJ is in the grey zone with still only limited risk for bankruptcy at the moment.
SJ's Altman-Z score of 2.76 is fine compared to the rest of the industry. SJ outperforms 72.00% of its industry peers.
SJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.76
ROIC/WACC0.29
WACC7.54%
SJ Yearly LT Debt VS Equity VS FCFSJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

SJ has a Current Ratio of 3.39. This indicates that SJ is financially healthy and has no problem in meeting its short term obligations.
SJ has a better Current ratio (3.39) than 90.67% of its industry peers.
SJ has a Quick Ratio of 3.39. This indicates that SJ is financially healthy and has no problem in meeting its short term obligations.
SJ's Quick ratio of 3.39 is amongst the best of the industry. SJ outperforms 90.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 3.39
SJ Yearly Current Assets VS Current LiabilitesSJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

SJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 214.62%, which is quite impressive.
SJ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.33% yearly.
The Revenue has decreased by -8.29% in the past year.
Measured over the past years, SJ shows a quite strong growth in Revenue. The Revenue has been growing by 8.31% on average per year.
EPS 1Y (TTM)214.62%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%-236.77%
Revenue 1Y (TTM)-8.29%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-3.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SJ Yearly Revenue VS EstimatesSJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.39, the valuation of SJ can be described as very reasonable.
Based on the Price/Earnings ratio, SJ is valued cheaper than 90.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of SJ to the average of the S&P500 Index (27.24), we can say SJ is valued rather cheaply.
Industry RankSector Rank
PE 9.39
Fwd PE N/A
SJ Price Earnings VS Forward Price EarningsSJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

SJ's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SJ is cheaper than 98.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.34
EV/EBITDA -1.81
SJ Per share dataSJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SJ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCIENJOY HOLDING CORP-A

NASDAQ:SJ (8/22/2025, 8:00:02 PM)

0.7509

+0 (+0.64%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-24 2025-11-24
Inst Owners0.21%
Inst Owner Change75.24%
Ins OwnersN/A
Ins Owner Change0%
Market Cap31.54M
Analysts0
Price TargetN/A
Short Float %0.04%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.39
Fwd PE N/A
P/S 0.17
P/FCF 3.34
P/OCF 3.29
P/B 0.19
P/tB 0.37
EV/EBITDA -1.81
EPS(TTM)0.08
EY10.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.22
FCFY29.91%
OCF(TTM)0.23
OCFY30.35%
SpS4.52
BVpS3.98
TBVpS2.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.31%
ROCE 3.27%
ROIC 2.22%
ROICexc 2.9%
ROICexgc 7.55%
OM 2.99%
PM (TTM) 2.91%
GM 18%
FCFM 4.97%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
ROICexc(3y)4.8%
ROICexc(5y)15.26%
ROICexgc(3y)11.69%
ROICexgc(5y)N/A
ROCE(3y)5.76%
ROCE(5y)14.57%
ROICexcg growth 3Y-44.13%
ROICexcg growth 5Y-50.35%
ROICexc growth 3Y-46.72%
ROICexc growth 5Y-58.97%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
F-Score8
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 6.41%
Cap/Sales 0.07%
Interest Coverage 250
Cash Conversion 122.43%
Profit Quality 170.66%
Current Ratio 3.39
Quick Ratio 3.39
Altman-Z 2.76
F-Score8
WACC7.54%
ROIC/WACC0.29
Cap/Depr(3y)12.27%
Cap/Depr(5y)22.76%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)214.62%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%-236.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.29%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-3.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.77%
EBIT growth 3Y-37.4%
EBIT growth 5Y-23.55%
EBIT Next Year714.3%
EBIT Next 3Y173.29%
EBIT Next 5Y128.25%
FCF growth 1Y-33.73%
FCF growth 3Y-16.15%
FCF growth 5Y-21.58%
OCF growth 1Y-33.09%
OCF growth 3Y-16.09%
OCF growth 5Y-21.39%